The “Lab Automation Market, 2023-2035” report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years.

Key Inclusions

§  An executive summary of the insights captured during our research, offering a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.

§  A general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.

§  A detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplate systems (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).

§  A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation system being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).

§  Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.

§  A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.

§  An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).

§  Informed estimates of the existing market size and the future opportunity for lab automation instruments, over the next 12 years. Based on multiple parameters, such as global instrumentation market in life science industry, biopharmaceutical industry and share of automation, we have provided informed estimates on the evolution of the market for the period 2023-2035.

§  A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories).

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

§  Stage of Automation

§  Pre-Analytical

§  Analytical

§  Post-Analytical

§  Total Lab Automation

§  Type of Instrument

§  Automated Liquid Handling Systems

§  Automated Microplate Readers

§  Automated Sampling Systems

§  Analyzers

§  Automated Storage and Retrieval Systems (ASRS)

§  Other Instruments

§  End-User

§  Pharmaceutical and Biotechnology Companies

§  Research and Diagnostic Laboratories

§  Other End-Users

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Middle East and North Africa

§  Latin America

Key Questions Answered

§  What is lab automation?

§  What is automated liquid handling system? What are examples of liquid handling systems?

§  How many players are currently involved in the development of lab automation systems?

§  Which are the top players in the lab automation market?

§  What is the global market size of the lab automation market?

§  What is the growth rate of lab automation market?

§  Which region is likely to hold the largest share in the lab automation market?

§  What is the market share of automated liquid handling systems?

§  What are the factors driving the lab automation market?

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/lab-automation-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:

§  Type of Product

§  Organ(s) based

§  Disease(s) based

§  Type of Application Area

§  Drug Discovery and Toxicity Testing

§  Cancer Research

§  Tissue Engineering and Regenerative Medicine

§  Stem Cell Research

§  Purpose

§  Research Use

§  Therapy Development

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:

§  BEOnChip

§  Dynamic42

§  Emulate

§  MIMETAS

§  SynVivo

§  TissUse

§  uFluidix

Table of Contents

1.      Preface

2.      Executive Summary

3.      Introduction

1.       Organ-on-Chip: Market Landscape

2.       Organ-on-Chip Developers: Company Profiles

3.       Patent Analysis

4.       Brand Positioning Matrix

5.       Academic Grants Analysis

6.       Partnerships and Collaborations

7.       Funding and Investment Analysis

8.       Case Study: Scaffold-Free 3D Cell Culture Systems

9.       Organ-on-Chip: Market Forecast and Opportunity Analysis

10.    Conclusion

14. Executive Insights

15. APPENDIX 1: TABULATED DATA

     16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:

§  Type of Product

§  Organ(s) based

§  Disease(s) based

§  Type of Application Area

§  Drug Discovery and Toxicity Testing

§  Cancer Research

§  Tissue Engineering and Regenerative Medicine

§  Stem Cell Research

§  Purpose

§  Research Use

§  Therapy Development

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:

§  BEOnChip

§  Dynamic42

§  Emulate

§  MIMETAS

§  SynVivo

§  TissUse

§  uFluidix

Table of Contents

1.      Preface

2.      Executive Summary

3.      Introduction

1.       Organ-on-Chip: Market Landscape

2.       Organ-on-Chip Developers: Company Profiles

3.       Patent Analysis

4.       Brand Positioning Matrix

5.       Academic Grants Analysis

6.       Partnerships and Collaborations

7.       Funding and Investment Analysis

8.       Case Study: Scaffold-Free 3D Cell Culture Systems

9.       Organ-on-Chip: Market Forecast and Opportunity Analysis

10.    Conclusion

14. Executive Insights

15. APPENDIX 1: TABULATED DATA

     16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

The “Tissue Engineering-based Regeneration Product Market, 2022-2035” report features an extensive study of the current landscape and the likely future potential of tissue engineering, over the next decade

Key Inclusions

§  A detailed review of the current market landscape of tissue engineering-based skin regeneration products based on several relevant parameters, such as type of graft (allografts / autografts / xenografts), area of application (burn healing / surgical healing / soft tissue skin regeneration / wound healing), type of material of scaffold (collagen-based tissues / human placental tissues / other human tissues / other animal-based tissues / other tissues) and launch year. In addition, the chapter lists the players providing tissue engineering-based skin regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).

§  A detailed review of the current market landscape of tissue engineering based-bone regeneration products based on several relevant parameters, such as type of graft (allografts / xenograft), formulation of product (bone matrix / bone putty / cortical fibers / powder / putty / sheet / sponge block), type of material of scaffold (bone tissue / collagen tissue / others / stem cell) and launch year. In addition, the chapter lists the players providing tissue engineering-based bone regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).

§  An in-depth analysis, highlighting the market trends through six different schematic representations, including [A] a world map representation, highlighting the regional distribution of the various tissue engineering based-regeneration products  providers, [B] a 4D bubble analysis comparing the key players engaged in this domain, based on several relevant parameters (such as year of establishment, company size, number of tissue engineering based-regeneration products offered and region), [C] an insightful spider web representation of tissue engineering based-regeneration products (based on type of graft and area of application), [D] a horizontal stacked bar chart representation presenting the distribution of tissue engineering based-regeneration products providers (based on area of application and material of scaffold), [E] a vertical stacked bar chart representation of tissue engineering-based regeneration products (distribution by product formulation and type of graft) and [F] a vertical stack  bar chart representation of tissue engineering based-regeneration products (distribution by region and type of market).

§  An insightful competitiveness analysis of players engaged in the development of tissue engineering-based regeneration products, based on several relevant parameters, such as years of experience, portfolio strength (in terms of area of applications,  material of scaffold, type of graft, number of products offered), partnerships activity (in terms of number of partnerships, year of partnerships, and type of partnerships), and funding activity (in terms of number of funding instances, amount of funding, year of funding, type of funding, and number of lead investors).

§  Elaborate profiles of prominent players that are currently engaged in offering tissue engineering-based regeneration products. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key executives). Additionally, the chapter includes company’s tissue regeneration product portfolio, details related to its recent developments and an informed future outlook.

§  An analysis of the various partnerships that have been inked between several stakeholders in the domain of tissue engineering-based regeneration products, during the period 2017-2022, covering

various type of partnership such as mergers and acquisitions, distribution agreements, product development and commercialization agreements, product utilization agreements, R&D agreements and others, along with analysis on recent investments during the period 2018 and 2022 (till the time of analysis) including grant, debt, seed funding, venture series, IPO, private equity, private placement, other equity and others. Further, it includes analysis of other recent initiatives taken by various stakeholders engaged in this domain.

§  An insightful analysis on filed / granted patents focused on tissue engineering-based regeneration products, during the period 2000-2022 (till the month when the research / analysis was conducted). The analysis highlights key details and trends associated with these patents, including patent type (granted patents / patent application / search reports / limited patent), publication year, geographical location (North America / Europe / Asia-Pacific / World Intellectual Property Organization), assigned CPC symbol, emerging focus area, type of applicant (industry / non-industry) and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.

§  An analysis that provides information on more than 750 grants that were awarded to various research institutes engaged in studies related to tissue engineering-based regeneration products, during the period 2018 and 2022 (till the time of analysis). The analysis also highlights important parameters associated with grants, The analysis also highlights important parameters associated with grants, such as year of award, support period, amount awarded, funding institute, administration institute center, funding institute center, funding mechanism, spending categorization, grant type (research grants (r series) / research training and fellowships (t & f series) / program project/center grants (p series) / others), responsible study section, focus area, type of recipient organization (schools of medicine / biomedical engineering /college of engineering/ schools of arts and sciences / independent hospitals / domestic for-profits / other domestic non-profits / schools of dentistry/oral hygn / research institutes / domestic higher education / others) and prominent program officers.

§  One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for tissue engineering-based regeneration products market for the next 13 years. Additionally, it features market size projections for the tissue engineering-based regeneration products market, wherein both the current and upcoming opportunity is segmented across [A] type of graft (allografts / autografts / xenografts), [B] area of application (bone healing / burn healing / surgical healing / would healing / others), [C] type of material of scaffold (bone tissue, collagen-based tissue, human placental tissue, other animal-based tissue, other human tissue,  stem cell and others tissues) and [D] key geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely the conservative, base and optimistic scenarios, which represent different tracks of the industry’s evolution.

By 2035, the financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:

§  Area of Application

§  Bone Healing

§  Burn Healing

§  Wound Healing

§  Surgical Healing

§  Others

§  Type of Graft

§  Allografts

§  Autografts

§  Xenografts

§  Key Geographical Regions

§  North America

§  Europe

§  Asia

§  Latin America

§  Middle East and North Africa

§  Rest of the World

Key Questions Answered

§  Who are the leading players engaged in providing tissue engineering-based regeneration products?

§  Which tissue engineering-based regeneration product is most commonly offered by developers?

§  What is the relative competitiveness of tissue engineering-based regeneration product providers?

§  What types of partnership models are commonly being adopted by stakeholders in this industry?

§  What is the trend for capital investments in the tissue engineering-based regeneration products market?

§  How has the patent landscape in this domain evolved over the last two decades?

§  What is the overall trend of grant activity related to tissue engineering-based regeneration products?

§  Which key market trends and driving factors are likely to impact the growth of the tissue engineering-based regeneration products market?

§  How is the current and future market opportunity likely to be distributed across key market segments?

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/tissue-engineering-market.html

You may also be interested in the following titles:

You may also like to learn what our experts are sharing in Roots educational series:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

Roots Analysis has announced the addition of “Medical Device Coatings Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the medical device coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Amongst other elements, the report includes:

§  A detailed executive summary of the insights captured during our research.

§  A detailed assessment of the current market landscape of medical device coating providers.

§  Detailed competitiveness analysis of various medical device coating providers.

§  A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.

§  Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.

§  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.

§  An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.

§  An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Type of Devices Coated 

§  Class I Medical Devices

§  Class II Medical Devices

§  Class III Medical Devices

§  Type of Coating Material

§  Polymer Coatings

§  Metal Coatings

§  Other Coatings

§  Company Size

§  Very Small

§  Small

§  Mid-sized

§  Large

§  Very Large

§  Key Geographical Region 

§  North America

§  Europe

§  Asia

§  Rest of the World 

Key companies covered in the report

§  Advanced Coating

§  Biocoat

§  Evonik

§  Formacoat

§  Harland Medical Systems

§  Para-Coat Technologies

§  Specialty Coating Systems

§  SurModics

§  TUA Systems

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/medical-device-coatings-market.html

You may also be interested in the following titles:

Cell Therapy Manufacturing Market

Global TCR Therapy Market

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

The “Global Cell Cytometry Market: Focus on High Throughput Flow Cytometers and Image Cytometers, 2022-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the global cell cytometry in the healthcare industry, in the mid to long term.

Key Inclusions

§  A general overview of cell cytometry, featuring information on the different types of cytometry, namely high throughput flow cytometry and image cytometry, along with details on their advantages and limitations. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.

§  A detailed assessment of the market landscape of high throughput flow cytometers based on several relevant parameters, such as type of high throughput flow cytometer, throughput rate (wells per minute), detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, sample volume (in µl), type of detection mechanism(s), and application(s). In addition, the chapter includes analysis of high throughput flow cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products offered).

§  An insightful product competitiveness analysis of high throughput flow cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of high throughput flow cytometer, throughput rate, detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions, sample volume (in µl), type of detection mechanism(s) and application(s)).

§  A detailed assessment of the market landscape of image cytometers based on several relevant parameters, such as type of image cytometer, processing time, type of plate format, output format, sample volume, and application(s). In addition, the chapter includes analysis of image cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).

§  An insightful product competitiveness analysis of image cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of image cytometer, processing time, output format, average sample volume and application(s)).

§  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in the development / commercialization of cell cytometers (high throughput flow cytometers and image cytometers). Each profile features a brief overview of the company, recent developments and an informed future outlook.

§  An insightful analysis of the partnerships that have been inked within the global cell cytometry industry since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, asset acquisitions, commercialization agreements, commercialization and distribution agreements, distribution agreements,  product development agreements storage and distribution agreements and others), most active players (in terms of number of deals inked) and regional distribution of partnership activity.

§  An analysis of various recent developments / trends related to global cell cytometry domain, offering insights on the funding activity in this domain, based on several relevant parameters, such as year of funding, type of funding, amount invested (USD Million), most active players (in terms of number of instances and amount raised), and most active investors (in terms of number of instances). In addition, it provides information on the analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, event platform, type of event, most active organizers (in terms of number of events) and most active organizations (in terms of number of participants).

§  An insightful analysis of the patents filed / granted for cell cytometry, since 2020, taking into consideration various relevant parameters, such as type of patent, publication year, annual number of granted patents and patent applications, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

§  Type of Cytometer

§  High Throughput Flow Cytometer

§  Image Cytometer

§  Company Size

§  Very Small

§  Small

§  Mid-sized

§  Large

§  Very Large

§  Key Geographical Regions 

§  North America

§  Europe

§  Asia-Pacific

§  Rest of the World

Key Questions Answered

§  Who are the leading players engaged in the development of high throughput flow cytometers and image cytometers?

§  Which are the popular types of cytometers available in the market?

§  Which partnership models are commonly adopted by stakeholders engaged in this industry?

§  What are the investment trends and who are the key investors actively engaged in the development and commercialization of cell cytometers?

§  What are the key agenda items being discussed in various global events / conferences held related to cell cytometry platforms?

§  How is the current and future market opportunity likely to be distributed across key market segments?

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/cell-cytometry-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com